The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s plasma protein therapeutics market report forecasts the plasma protein therapeutics market size to grow to $35.84 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Plasma Protein Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Plasma Protein Therapeutics Market Size Forecast
The global plasma protein therapeutics market is expected to grow from $26.25 billion in 2022 to $28.11 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global plasma protein therapeutics market size is expected to reach $35.84 billion in 2027 at a CAGR of 6.3%.

North America held the largest plasma protein therapeutics market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Plasma Protein Therapeutics Market Driver ­– Increase In The Prevalence Of Autoimmune Disorders
According to Scientific American, a science journal located in the United States, autoimmune illnesses will impact approximately 4% of the global population in September 2021. Furthermore, according to the National Library of Medicine, a biomedical library based in the United States, autoimmunity diseases have a 2 to 1 prevalence rate for women in May 2020. As a result, the rising prevalence of autoimmune illnesses is propelling the plasma protein therapies market ahead.

Request for A Sample Of The Global Plasma Protein Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Key Plasma Protein Therapeutics Market Trend – Product Innovations
To achieve a competitive advantage in the market, major companies in the plasma protein therapy sector are focusing on innovative goods. For example, Biognosys, a Swiss biotechnology business, developed an innovative next-generation blood biomarker discovery solution in November 2021. The programme is meant to aid researchers in interpreting the complexity of the blood proteome and unlocking unbiased findings for pharmacological, diagnostic, and precision medicine development. Biognosys’ Hyper Reaction Monitoring (HRMTM) technology and optimised Liquid Chromatography-Mass Spectrometry (LC-MS) process distinguish both systems.

Plasma Protein Therapeutics Market Segment
1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Plasma Protein Therapeutics Market Major Players and Strategies
Major players in the plasma protein therapeutics market are Octapharma AG, CSL Behring LLC, Grifols S.A, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion S.p.A., Shire PLC., LFB GROUP, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions B.V., Bio Products Laboratory Ltd., and MP Biomedicals LLC.

Grifols S.A, a Spanish pharmaceutical and chemical firm, paid €1.6 billion ($1.72 billion) in April 2022 to buy Tiancheng (Germany) Pharmaceutical Holdings AG. This acquisition is expected to speed up and broaden Grifols’ product portfolio, boost patient access to plasma medicines, and generate revenue growth and profitability expansion. Biotest is a healthcare firm established in Germany that specialises in novel haematology and clinical immunology, as well as designing, manufacturing, and distributing plasma proteins and biotherapeutic medicines.

The Plasma Protein Therapeutics Global Market Report 2023 covers regional data on plasma protein therapeutics market size, plasma protein therapeutics market trends and drivers, opportunities, strategies, and plasma protein therapeutics market competitor analysis. The countries covered in the plasma protein therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Plasma protein treatments are medications made from plasma or its recombinant analogues. It treats certain medical diseases by replacing missing or inadequate proteins in plasma, letting recipients to live healthier and more productive lives.

View More Reports Related To The Plasma Protein Therapeutics Market –
Protein Expression Global Market Report 2023
Plasma Therapy Global Market Report 2023
Antisense & RNAi Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: